NO20031308L - Effektiv fremgangsmåte for fremstilling av en faktor XA- inhibitor - Google Patents

Effektiv fremgangsmåte for fremstilling av en faktor XA- inhibitor

Info

Publication number
NO20031308L
NO20031308L NO20031308A NO20031308A NO20031308L NO 20031308 L NO20031308 L NO 20031308L NO 20031308 A NO20031308 A NO 20031308A NO 20031308 A NO20031308 A NO 20031308A NO 20031308 L NO20031308 L NO 20031308L
Authority
NO
Norway
Prior art keywords
inhibitor
preparing
factor
effective method
effective
Prior art date
Application number
NO20031308A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031308D0 (no
Inventor
Luigi Anzalone
Fuqiang Jin
David J Meloni
Jung-Hui Sun
Christopher A Teleha
Jia Cheng Zhou
Thomas E Smyser
Hui-Yin Li
Original Assignee
Bristol Myers Squibb Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Pharma Co filed Critical Bristol Myers Squibb Pharma Co
Publication of NO20031308D0 publication Critical patent/NO20031308D0/no
Publication of NO20031308L publication Critical patent/NO20031308L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20031308A 2000-09-22 2003-03-21 Effektiv fremgangsmåte for fremstilling av en faktor XA- inhibitor NO20031308L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23462200P 2000-09-22 2000-09-22
PCT/US2001/028406 WO2002024690A2 (en) 2000-09-22 2001-09-12 Efficient process for the preparation of a factor xa inhibitor

Publications (2)

Publication Number Publication Date
NO20031308D0 NO20031308D0 (no) 2003-03-21
NO20031308L true NO20031308L (no) 2003-05-07

Family

ID=22882119

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031308A NO20031308L (no) 2000-09-22 2003-03-21 Effektiv fremgangsmåte for fremstilling av en faktor XA- inhibitor

Country Status (23)

Country Link
US (3) US6667332B2 (xx)
EP (1) EP1366045A2 (xx)
JP (1) JP2004529853A (xx)
KR (1) KR20040043089A (xx)
CN (1) CN1610679A (xx)
AU (1) AU2001292612A1 (xx)
BG (1) BG107813A (xx)
BR (1) BR0114102A (xx)
CA (1) CA2424576A1 (xx)
CZ (1) CZ2003835A3 (xx)
EE (1) EE200300116A (xx)
HR (1) HRP20030316A2 (xx)
HU (1) HUP0500133A2 (xx)
IL (1) IL155043A0 (xx)
IS (1) IS6754A (xx)
MX (1) MXPA03002493A (xx)
NO (1) NO20031308L (xx)
PL (1) PL366027A1 (xx)
RU (1) RU2003111464A (xx)
SK (1) SK4892003A3 (xx)
TW (1) TW593314B (xx)
WO (1) WO2002024690A2 (xx)
ZA (1) ZA200302971B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339099B1 (en) * 1997-06-20 2002-01-15 Dupont Pharmaceuticals Company Guanidine mimics as factor Xa inhibitors
IL153378A0 (en) * 2000-07-18 2003-07-06 Bone Care Internat Inc STABILIZED 1alpha-HYDROXY VITAMIN D
TW200302225A (en) * 2001-12-04 2003-08-01 Bristol Myers Squibb Co Substituted amino methyl factor Xa inhibitors
AU2003270861A1 (en) * 2002-10-02 2004-04-23 Bristol-Myers Squibb Company Novel combination of a factor xa inhibitor and clopidogrel
WO2004041710A1 (ja) * 2002-11-06 2004-05-21 Matsushita Electric Industrial Co., Ltd. 変位検出機能を備えたマイクロアクチュエータ、および当該マイクロアクチュエータを備えた可変形ミラー
US7429581B2 (en) * 2002-12-23 2008-09-30 Sanofi-Aventis Deutschland Gmbh Pyrazole-derivatives as factor Xa inhibitors
US20050059719A1 (en) * 2003-09-16 2005-03-17 Badawy Sherif Ibrahim Farag Solid dosage formulation containing a Factor Xa inhibitor and method
MX2016011468A (es) 2014-03-07 2017-01-23 Biocryst Pharm Inc Inhibidores de calicreína plasmática humana.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020357A (en) * 1996-12-23 2000-02-01 Dupont Pharmaceuticals Company Nitrogen containing heteroaromatics as factor Xa inhibitors
ZA985247B (en) * 1997-06-19 1999-12-17 Du Pont Merck Pharma Guanidine mimics as factor Xa inhibitors.
US6339099B1 (en) * 1997-06-20 2002-01-15 Dupont Pharmaceuticals Company Guanidine mimics as factor Xa inhibitors

Also Published As

Publication number Publication date
TW593314B (en) 2004-06-21
CA2424576A1 (en) 2002-03-28
BG107813A (bg) 2004-01-30
ZA200302971B (en) 2005-05-09
CN1610679A (zh) 2005-04-27
IS6754A (is) 2003-03-21
US20020061917A1 (en) 2002-05-23
IL155043A0 (en) 2003-10-31
WO2002024690A3 (en) 2003-09-25
AU2001292612A1 (en) 2002-04-02
NO20031308D0 (no) 2003-03-21
RU2003111464A (ru) 2004-10-27
BR0114102A (pt) 2005-04-19
MXPA03002493A (es) 2004-09-10
EP1366045A2 (en) 2003-12-03
HRP20030316A2 (en) 2005-02-28
EE200300116A (et) 2005-04-15
PL366027A1 (en) 2005-01-24
US20030212117A1 (en) 2003-11-13
WO2002024690A8 (en) 2002-08-08
US6747158B2 (en) 2004-06-08
CZ2003835A3 (cs) 2003-12-17
SK4892003A3 (en) 2004-04-06
US6667332B2 (en) 2003-12-23
US20040198787A1 (en) 2004-10-07
KR20040043089A (ko) 2004-05-22
JP2004529853A (ja) 2004-09-30
HUP0500133A2 (hu) 2005-04-28
WO2002024690A2 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
NO20021230D0 (no) Inhibitorer for faktor Xa
ATE346050T1 (de) Substituierte oxoazaheterocyclyl faktor xa hemmer
NO20042592L (no) Indol-2-karboksamider som faktor XA inhibitorer
NO20013072L (no) Nitrogenholdige heterocykler som faktor Xa-inhibitorer
IL149292A0 (en) Method for graphically defining a formula
DK1526132T3 (da) Substituerede oxazolidinoner og deres anvendelse som faktor Xa-hæmmer
NO20071888L (no) Fremgangsmate for a syntetisere 4-aminosubstituerte forbindelser
NO996316D0 (no) Faktor Xa-inhibitorer med en noeytral P1-spesifisitetsgruppe
FI20000099A0 (fi) Menetelmä metalliohutkalvojen kasvattamiseksi
NO20011293D0 (no) Faktor VIIa-inhibitorer
DE60123294D1 (de) Diazepan Derivate als Faktor X Inhibitor
DE60113024T2 (de) Vorrichtung zum schutz einer wand
NO20021414D0 (no) Fremgangsmåte for forbedring av permeabiliteten av en undergrunnspetroleuminneholdende formasjon
NO20042990L (no) Pyrrolidin-2-oner som faktor XA inhibitorer
NO20031308L (no) Effektiv fremgangsmåte for fremstilling av en faktor XA- inhibitor
DK1189929T3 (da) Faktor VIIa-inhibitorer
FI20000869A (fi) Menetelmä kiinnirullaimen toimintavarmuuden parantamiseksi
ATE305452T1 (de) Faktor xa inhibitor
NO20032366L (no) Fremgangsmåte for produksjon av en hydraulisk trubinkomponent
FI113053B (fi) Menetelmä polyaniliinin valmistamiseksi
FR2802198B1 (fr) Machine a sections individuelles
NO324220B1 (no) Fremgangsmate for fremstilling av en polymorf
ITVI990085A0 (it) Macchina di ribobinatura a spire accostate
DE60134162D1 (de) Neue kristalline formen eines faktor xa inhibitors
FI20002268A0 (fi) Menetelmä paperin kuituorientaation hallitsemiseksi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application